Matchpoint Therapeutics is a privately held biotechnology company based in Watertown, Massachusetts, developing breakthrough oral medicines for autoimmune and inflammatory diseases. The company is pioneering a new generation of rationally designed covalent small molecules for biologically validated targets that have been historically hard to drug. Matchpoint's discovery engine integrates deep expertise across chemical biology, covalent chemistry, structure-based drug design, and computational sciences. The company's focused deployment of its platform has produced a pipeline of first-in-class programs and a discovery collaboration with Novartis.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
10/07/26	$150,000,000	Series B	Access Biotechnology Atlas Venture BB Biotech Ventures BOLD Longevity Growth Digitalis Ventures Invus Nextech Invest Norwest Venture Partners Sanofi Ventures T1D Fund	undisclosed